S&P 500   3,324.66 (+0.55%)
DOW   27,146.74 (+1.19%)
QQQ   270.73 (+0.13%)
AAPL   438.35 (-0.07%)
MSFT   212.59 (-0.33%)
FB   250.80 (+0.39%)
GOOGL   1,484.07 (+0.73%)
AMZN   3,183.70 (+1.43%)
NVDA   450.76 (+0.37%)
CGC   18.97 (-1.81%)
BABA   263.33 (+0.43%)
TSLA   1,482.36 (-0.31%)
MU   51.05 (-0.49%)
GE   6.16 (+0.33%)
AMD   85.55 (+0.59%)
T   29.84 (-0.57%)
F   6.97 (+1.60%)
ACB   10.57 (-1.49%)
GILD   69.25 (-2.30%)
NFLX   503.75 (-1.16%)
DIS   129.90 (+10.75%)
BAC   25.43 (+1.68%)
BA   171.83 (+4.10%)
S&P 500   3,324.66 (+0.55%)
DOW   27,146.74 (+1.19%)
QQQ   270.73 (+0.13%)
AAPL   438.35 (-0.07%)
MSFT   212.59 (-0.33%)
FB   250.80 (+0.39%)
GOOGL   1,484.07 (+0.73%)
AMZN   3,183.70 (+1.43%)
NVDA   450.76 (+0.37%)
CGC   18.97 (-1.81%)
BABA   263.33 (+0.43%)
TSLA   1,482.36 (-0.31%)
MU   51.05 (-0.49%)
GE   6.16 (+0.33%)
AMD   85.55 (+0.59%)
T   29.84 (-0.57%)
F   6.97 (+1.60%)
ACB   10.57 (-1.49%)
GILD   69.25 (-2.30%)
NFLX   503.75 (-1.16%)
DIS   129.90 (+10.75%)
BAC   25.43 (+1.68%)
BA   171.83 (+4.10%)
S&P 500   3,324.66 (+0.55%)
DOW   27,146.74 (+1.19%)
QQQ   270.73 (+0.13%)
AAPL   438.35 (-0.07%)
MSFT   212.59 (-0.33%)
FB   250.80 (+0.39%)
GOOGL   1,484.07 (+0.73%)
AMZN   3,183.70 (+1.43%)
NVDA   450.76 (+0.37%)
CGC   18.97 (-1.81%)
BABA   263.33 (+0.43%)
TSLA   1,482.36 (-0.31%)
MU   51.05 (-0.49%)
GE   6.16 (+0.33%)
AMD   85.55 (+0.59%)
T   29.84 (-0.57%)
F   6.97 (+1.60%)
ACB   10.57 (-1.49%)
GILD   69.25 (-2.30%)
NFLX   503.75 (-1.16%)
DIS   129.90 (+10.75%)
BAC   25.43 (+1.68%)
BA   171.83 (+4.10%)
S&P 500   3,324.66 (+0.55%)
DOW   27,146.74 (+1.19%)
QQQ   270.73 (+0.13%)
AAPL   438.35 (-0.07%)
MSFT   212.59 (-0.33%)
FB   250.80 (+0.39%)
GOOGL   1,484.07 (+0.73%)
AMZN   3,183.70 (+1.43%)
NVDA   450.76 (+0.37%)
CGC   18.97 (-1.81%)
BABA   263.33 (+0.43%)
TSLA   1,482.36 (-0.31%)
MU   51.05 (-0.49%)
GE   6.16 (+0.33%)
AMD   85.55 (+0.59%)
T   29.84 (-0.57%)
F   6.97 (+1.60%)
ACB   10.57 (-1.49%)
GILD   69.25 (-2.30%)
NFLX   503.75 (-1.16%)
DIS   129.90 (+10.75%)
BAC   25.43 (+1.68%)
BA   171.83 (+4.10%)
Log in

NASDAQ:GOSSGossamer Bio News Headlines

$13.11
+0.16 (+1.24 %)
(As of 08/5/2020 12:08 PM ET)
Add
Compare
Today's Range
$12.86
Now: $13.11
$13.11
50-Day Range
$11.92
MA: $13.02
$14.75
52-Week Range
$7.52
Now: $13.11
$27.15
Volume4,696 shs
Average Volume611,354 shs
Market Capitalization$869.98 million
P/E RatioN/A
Dividend YieldN/A
Beta1.06

Headlines

Gossamer Bio (NASDAQ GOSS) News Headlines

Source:
DateHeadline
Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual ConferenceGossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual Conference
finance.yahoo.com - August 5 at 10:36 AM
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.5%Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.5%
americanbankingnews.com - August 3 at 9:08 PM
Gossamer Bio Inc (NASDAQ:GOSS) Short Interest UpdateGossamer Bio Inc (NASDAQ:GOSS) Short Interest Update
www.americanbankingnews.com - August 1 at 1:06 AM
Gossamer Bio (NASDAQ:GOSS)  Shares Down 5.5% Gossamer Bio (NASDAQ:GOSS) Shares Down 5.5%
www.americanbankingnews.com - July 31 at 8:18 PM
Gossamer Bio Inc (NASDAQ:GOSS) Receives Average Rating of "Buy" from AnalystsGossamer Bio Inc (NASDAQ:GOSS) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 31 at 1:54 AM
Critical Review: Humanigen (OTCMKTS:HGEN) versus Gossamer Bio (OTCMKTS:GOSS)Critical Review: Humanigen (OTCMKTS:HGEN) versus Gossamer Bio (OTCMKTS:GOSS)
www.americanbankingnews.com - July 25 at 8:28 PM
Could The Gossamer Bio, Inc. (NASDAQ:GOSS) Ownership Structure Tell Us Something Useful?Could The Gossamer Bio, Inc. (NASDAQ:GOSS) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - July 22 at 2:33 PM
Gossamer Bios Shares March Higher, Can It Continue?Gossamer Bio's Shares March Higher, Can It Continue?
www.nasdaq.com - July 22 at 9:32 AM
Gossamer Bio's Shares March Higher, Can It Continue?Gossamer Bio's Shares March Higher, Can It Continue?
finance.yahoo.com - July 22 at 9:32 AM
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 5.1%Gossamer Bio (NASDAQ:GOSS) Stock Price Down 5.1%
www.americanbankingnews.com - July 20 at 9:09 PM
Brokers Issue Forecasts for Gossamer Bio Incs FY2020 Earnings (NASDAQ:GOSS)Brokers Issue Forecasts for Gossamer Bio Inc's FY2020 Earnings (NASDAQ:GOSS)
www.americanbankingnews.com - July 16 at 7:19 AM
Gossamer Bio (NASDAQ:GOSS) PT Raised to $33.00Gossamer Bio (NASDAQ:GOSS) PT Raised to $33.00
www.americanbankingnews.com - July 14 at 8:31 AM
Is Gossamer Bio, Inc. (GOSS) A Good Stock To Buy?Is Gossamer Bio, Inc. (GOSS) A Good Stock To Buy?
finance.yahoo.com - July 3 at 7:01 PM
BRIEF-Gossamer Bio Says Units Entered Into Second Amendment To Credit, Guaranty And Security AgreementBRIEF-Gossamer Bio Says Units Entered Into Second Amendment To Credit, Guaranty And Security Agreement
www.reuters.com - July 2 at 6:02 PM
Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of GlaucomaAerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
finance.yahoo.com - June 8 at 12:28 PM
GOSS FINAL DEADLINE TODAY: Rosen, a Top Ranked Law Firm, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action – GOSSGOSS FINAL DEADLINE TODAY: Rosen, a Top Ranked Law Firm, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action – GOSS
finance.yahoo.com - June 2 at 12:41 PM
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - June 2 at 12:41 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBYThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBY
finance.yahoo.com - June 2 at 12:41 PM
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the FirmFINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 2 at 12:41 PM
LAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMSLAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
finance.yahoo.com - June 2 at 12:41 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, GSX and BIDUThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, GSX and BIDU
finance.yahoo.com - June 2 at 7:34 AM
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - June 1 at 10:10 AM
GOSS FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020GOSS FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020
finance.yahoo.com - June 1 at 10:10 AM
TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmTUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 31 at 10:59 PM
2-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm2-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 31 at 12:56 PM
FINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmFINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 30 at 7:28 PM
FINAL DEADLINE: ROSEN, A TRUSTED AND RANKED FIRM, Encourages Gossamer Bio, Inc. Investors with Losses to Contact Firm Before Important June 2 Deadline in Securities Class Action- GOSSFINAL DEADLINE: ROSEN, A TRUSTED AND RANKED FIRM, Encourages Gossamer Bio, Inc. Investors with Losses to Contact Firm Before Important June 2 Deadline in Securities Class Action- GOSS
finance.yahoo.com - May 30 at 7:28 PM
BRIEF-Gossamer Bio Announces Early Encouraging Safety And Biomarker Data From Phase 1/2 Study Of Gb1275BRIEF-Gossamer Bio Announces Early Encouraging Safety And Biomarker Data From Phase 1/2 Study Of Gb1275
www.reuters.com - May 29 at 1:18 PM
GOSS FINAL DEADLINE TUESDAY: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action – GOSSGOSS FINAL DEADLINE TUESDAY: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action – GOSS
finance.yahoo.com - May 29 at 1:18 PM
Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific ProgramGossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program
finance.yahoo.com - May 29 at 8:17 AM
JUNE 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmJUNE 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 27 at 11:32 PM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VMW, GOSS and DNKThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of VMW, GOSS and DNK
finance.yahoo.com - May 27 at 6:32 PM
FINAL DEADLINE JUNE 2: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmFINAL DEADLINE JUNE 2: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 26 at 7:20 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, IQ and HALLThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, IQ and HALL
finance.yahoo.com - May 26 at 7:20 PM
GOSS SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020GOSS SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020
finance.yahoo.com - May 26 at 2:19 PM
CLASS ACTION UPDATE for GOSS, BIDU and DNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for GOSS, BIDU and DNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - May 26 at 2:19 PM
Notice of June 2, 2020 Lead Plaintiff Deadline for Shareholders in the Gossamer Bio, Inc. Securities Class Action LawsuitNotice of June 2, 2020 Lead Plaintiff Deadline for Shareholders in the Gossamer Bio, Inc. Securities Class Action Lawsuit
finance.yahoo.com - May 26 at 9:18 AM
Shareholder Alert: Robbins LLP Announces Gossamer Bio, Inc. (GOSS) Sued for Misleading ShareholdersShareholder Alert: Robbins LLP Announces Gossamer Bio, Inc. (GOSS) Sued for Misleading Shareholders
finance.yahoo.com - May 22 at 5:49 PM
GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited ShareholdersGOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders
finance.yahoo.com - May 20 at 8:52 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSSSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS
finance.yahoo.com - May 19 at 5:51 PM
Why Gossamer Bio Stock Is Tumbling TodayWhy Gossamer Bio Stock Is Tumbling Today
finance.yahoo.com - May 19 at 12:50 PM
CLASS ACTION UPDATE for ANAB, GOSS and WORX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for ANAB, GOSS and WORX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - May 19 at 12:50 PM
Lawsuits Filed Against GOSS, BBBY and GRPN - Jakubowitz Law Pursues Shareholders ClaimsLawsuits Filed Against GOSS, BBBY and GRPN - Jakubowitz Law Pursues Shareholders Claims
finance.yahoo.com - May 19 at 7:50 AM
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmIMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 19 at 1:42 AM
Gossamer Bio Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027Gossamer Bio Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
finance.yahoo.com - May 19 at 1:42 AM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, MESA and GOSSThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, MESA and GOSS
finance.yahoo.com - May 18 at 3:41 PM
CLASS ACTION UPDATE for GOSS, LBRT and LOPE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for GOSS, LBRT and LOPE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - May 18 at 10:39 AM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, LBRT and GSXThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, LBRT and GSX
finance.yahoo.com - May 18 at 10:39 AM
DEADLINE APPROACHING: Block & Leviton Filed the First Lawsuit Against Gossamer Bio, Inc. for Securities Fraud; Shareholders Who Have Lost Money Should Contact the FirmDEADLINE APPROACHING: Block & Leviton Filed the First Lawsuit Against Gossamer Bio, Inc. for Securities Fraud; Shareholders Who Have Lost Money Should Contact the Firm
finance.yahoo.com - May 18 at 10:39 AM
Atara Biotherapeutics Names Cell Therapy & Oncology Leader Jakob Dupont, M.D. as Global Head of Research & DevelopmentAtara Biotherapeutics Names Cell Therapy & Oncology Leader Jakob Dupont, M.D. as Global Head of Research & Development
www.businesswire.com - May 14 at 5:13 PM
This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.